FDA product code NSU: Instrumentation For Clinical Multiplex Test Systems

NSU is the FDA product code for instrumentation for clinical multiplex test systems. It is a Class II device, regulated under 21 CFR 862.2570 and reviewed by the Clinical Chemistry panel. FDA has cleared 12 510(k) submissions under NSU, from 10 different applicants. The average 510(k) review took 150 days (median 141). 1 De Novo request was granted under it. FDA has posted 14 recalls for NSU devices, 5 initiated in the last five years.

Definition

Instrumentation for clinical multiplex test systems is a device that is intended to measure and sort multiple signals generated by an assay from a clinical sample. The generated signals from multiple probes or other ligands may be measured by fluorescence, luminescence, or other physical or chemical properties. The device may integrate scanning, reagent handling, hybridization, washing, dedicated instrument control, data acquisition software, raw data storage mechanisms and other essential hardware components along with the signal reader unit. This instrumentation is used with specific assays to comprise an assay test system to measure multiple analytes of a similar chemical nature for de

Classification

FieldValue
Device nameInstrumentation For Clinical Multiplex Test Systems
Device classClass II
Regulation21 CFR 862.2570
Review panelCH — Clinical Chemistry
Medical specialtyClinical Chemistry
Premarket route510(k) exempt

510(k) clearances per year for NSU

YearClearancesAvg. review days
20171168

Compare with all 510(k) review times · Search every NSU clearance

Top NSU applicants

ApplicantClearancesLatest
Luminex Corp.32014-01-10
Genmark Diagnostics, Incorporated12017-06-09
Biofire Diagnostics, LLC12015-01-30
Liposcience12014-10-22
Thermo Fisher Scientific (Life Technologies Holdin12014-05-22

5 more applicants have NSU clearances. See the full list in Caduvo.

Most recent NSU clearances

510(k)ApplicantDeviceDecision dateReview days
K163652Genmark Diagnostics, IncorporatedePlex Instrument2017-06-09168
K143178Biofire Diagnostics, LLCFilmArray 2.0 System2015-01-3087
K133849LiposcienceVANTERA CLINICAL ANALYZER2014-10-22307
K141220Thermo Fisher Scientific (Life Technologies HoldinAPPLIED BIOSYSTEMS 7500 FAST DX REAL-TIME PCR INSTRUMENT WITH SDS SOFTWARE2014-05-2210
K133302Luminex Corp.FLEXMAP 3D2014-01-1077

Recalls for NSU devices

14 product recalls in 12 recall events; 5 initiated in the last five years and 6 still open. Most recent: 2025-10-22.

YearRecalls
20174
20181
20191
20201
20211
20221
20231
20241
20252

Frequently asked questions

What is FDA product code NSU?

NSU is the FDA product code for instrumentation for clinical multiplex test systems. It is a Class II device, regulated under 21 CFR 862.2570 and reviewed by the Clinical Chemistry panel.

What device class is NSU?

Class II, regulation 21 CFR 862.2570. Typical premarket route: 510(k) exempt.

How long does a 510(k) take for product code NSU?

Across 12 cleared submissions the average was 150 days from receipt to decision (median 141).

Which companies have the most NSU clearances?

Luminex Corp. (3); Genmark Diagnostics, Incorporated (1); Biofire Diagnostics, LLC (1); Liposcience (1); Thermo Fisher Scientific (Life Technologies Holdin (1).

Have NSU devices been recalled?

Yes: 14 product recalls across 12 recall events; the most recent began 2025-10-22.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times